ISIS 3521/CGP64128A antisense inhibitor of protein kinase C data

At the Royal College of Physicians and Surgeons meeting in Vancouver, ISIP presented results from two Phase I studies in patients with a variety of cancers

Read the full 269 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE